Overview
The press release announces that Glutone is expanding its portfolio with a new daily skin‑nutrition tablet, Glutone‑A, reflecting a broader consumer move away from solely topical skincare toward internal supplementation. The narrative explains that many disciplined users of multi‑step routines experience a plateau in visible results, prompting a search for solutions that address internal factors such as sleep, stress, diet and oxidative stress.
Drivers of the Shift
Three primary reasons are cited for the change: (1) plateaued outcomes from existing topical products, (2) heightened awareness of antioxidants—particularly glutathione and related compounds—and (3) the convenience of a pill or effervescent drink compared with complex regimens. A holistic mindset that blurs the line between beauty and wellness further fuels interest in ingestible skin‑support products.
Product Details – Glutone‑A
Glutone‑A is described as a tablet formulated with Japanese Opitac Glutathione and Alpha Lipoic Acid (ALA). The combination is intended to provide antioxidant protection and to address specific concerns including pigmentation, dark spots, tanning and uneven skin tone from within. The release emphasizes that the active ingredients are present in clinically meaningful doses and are paired to support absorption.
Complementary Offerings
In addition to Glutone‑A, the brand markets hydration‑focused tablets, easy mouth‑dissolving melts, and topical items such as a face serum and face wash. All products are positioned to enhance, not replace, a consistent skincare routine that includes cleansing, sun protection and hydration.
Strategic Positioning
Glutone frames daily skin nutrition as an “inside‑out” approach that works alongside external products, suggesting that the supplement layer can amplify the effectiveness of serums and creams. The company argues that as consumers become more educated about internal determinants of skin health, ingestible supplements will become as routine as sunscreen.
Disclaimer
The release notes that it is provided under an arrangement with PNN and that PTI assumes no editorial responsibility for its content.